Words that describe feelings lost in dementia

July 27, 2012 in Alzheimer's disease & dementia

(Medical Xpress) -- Dementia can affect a person’s ability to recognise the meaning of common emotional words such as ‘thrilled’ and ‘annoyed’, according to new research.

Dr Sharpley Hsieh and colleagues from Neuroscience Research Australia explored how people with different types of dementia comprehend words describing , such as ‘doubt’ and ‘hopeful’.

“People use emotion words in everyday conversation and don’t realise it. How often do we use sentences such as ‘I’m frustrated’ or ‘she’s impressed’? These are key words and you have to know them to understand a sentence,” Dr Hsieh says.

Dr Hsieh found that people with Alzheimer’s disease are still able to understand these kinds of words, but people with other types of dementia are not.

People suffering from semantic dementia – a type of frontotemporal dementia and the second most common dementia in people under 65 – experience a severe loss of word and conceptual knowledge. This latest study confirms that for this group of people, their understanding of emotion words is also severely affected.

“You can easily show a picture of a car to test this word, or a smiling face to show happiness. But feelings such as frustration or embarrassment are difficult to depict and so until now we haven’t been able to look at whether these concepts are lost in people with different dementias,” Dr Hsieh says.

These findings have implications for sufferers of , carers and families.

“Losing the concept of a toaster, for example, will impact upon a person’s quality of life, but the prevalence of words used to communicate feelings and emotion in our language must make the lack of understanding of these so devastating for patients and their carers,” Dr Hsieh says.

This study is published in the journal Neuropsychology.

More information:

How was this study done?

-- People with semantic dementia, behavioural-variant frontotemporal dementia, and Alzheimer’s disease were compared to healthy people without any dementia.
-- Two tests were given. The first asked patients to couple feelings such as ‘anger’ with ‘fury’ or ‘remorse’; the second asked patients to associate words such as ‘terror’ in the right context such as ‘hiding’ or ‘playing’.
-- Patients with Alzheimer’s disease demonstrated the most successful level of comprehension across tests; people with behavioural-variant frontotemporal dementia showed a mixed response depending on the test.
-- Patients with semantic dementia were the most impaired on both tests.

Provided by Neuroscience Research Australia search and more info website

not rated yet  

Rank not rated yet
Relevant PhysicsForums posts

More news stories

A new strategy required in the search for Alzheimer's drugs?

In the search for medication against Alzheimer's disease, scientists have focused – among other factors – on drugs that can break down Amyloid beta (A-beta). After all, it is the accumulation of A-beta that causes the ...

Alzheimer's disease & dementia created May 24, 2013 | popularity not rated yet | comments 0

Alzheimer's disease, the soft target of the euthanasia debate

(Medical Xpress)—The way Alzheimer's disease is portrayed by advocacy groups and the media is having undue influence on the euthanasia debate, according to a Deakin University nursing ethics professor.

Alzheimer's disease & dementia created May 24, 2013 | popularity not rated yet | comments 2

Scientists discover cinnamon compounds' potential ability to prevent Alzheimer's

Cinnamon: Can the red-brown spice with the unmistakable fragrance and variety of uses offer an important benefit? The common baking spice might hold the key to delaying the onset of –– or warding off ...

Alzheimer's disease & dementia created May 23, 2013 | popularity 5 / 5 (5) | comments 0 | with audio podcast

Drug reverses Alzheimer's disease deficits in mice, research confirms

An anti-cancer drug reverses memory deficits in an Alzheimer's disease mouse model, University of Pittsburgh Graduate School of Public Health researchers confirm in the journal Science.

Alzheimer's disease & dementia created May 23, 2013 | popularity not rated yet | comments 0 | with audio podcast

Multiple research teams unable to confirm high-profile Alzheimer's study

Teams of highly respected Alzheimer's researchers failed to replicate what appeared to be breakthrough results for the treatment of this brain disease when they were published last year in the journal Science.

Alzheimer's disease & dementia created May 23, 2013 | popularity 3 / 5 (2) | comments 3 | with audio podcast


First drug to improve heart failure mortality in over a decade

Coenzyme Q10 decreases all cause mortality by half, according to the results of a multicentre randomised double blind trial presented today at Heart Failure 2013 congress. It is the first drug to improve heart failure mortality ...

Seniors more likely to crash when driving with pet, study finds

(HealthDay)—Animals make great companions for senior citizens, but elderly people who always drive with a pet in the car are far more likely to crash than those who never drive with a pet, researchers have ...

Heart failure accelerates male 'menopause'

Heart failure accelerates the aging process and brings on early andropausal syndrome (AS), according to research presented today at the Heart Failure Congress 2013. AS, also referred to as male 'menopause', was four times ...

Death highest in heart failure patients admitted in January, on Friday, and overnight

Mortality and length of stay are highest in heart failure patients admitted in January, on Friday, and overnight, according to research presented today at the Heart Failure Congress 2013. The analysis of nearly 1 million ...

Feds fight morning-after pill age ruling in NY

(AP)—Department of Justice lawyers have again asked a federal appeals court in New York to delay lifting age restrictions and prescription requirements on an emergency contraceptive popularly known as the morning-after ...

New immune system discovered

(Medical Xpress)—A research team, led by Jeremy Barr, a biology post-doctoral fellow, unveils a new immune system that protects humans and animals from infection.